XML 57 R39.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair Value Measurements - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended 12 Months Ended
Jul. 01, 2018
Jul. 02, 2017
Jul. 01, 2018
Jul. 02, 2017
Dec. 31, 2017
Jan. 01, 2018
Derivative [Line Items]            
Available-for-sale Securities, Equity Securities $ 697   $ 697   $ 751  
Accumulated other comprehensive income on derivatives, after tax (80)   $ (80)      
Reclassification of foreign exchange contracts into earnings, period     next 12 months      
Maximum length of time for hedge exposure     18 months      
Unrealized gains on equity investments $ 0 $ 47 $ 0 $ 136    
Weighted average interest rate on non-current debt 3.20%   3.20%      
Excess of the estimated fair value over the carrying value of debt         2,000  
Foreign exchange contracts            
Derivative [Line Items]            
Collateral Already Posted, Aggregate Fair Value $ 126   $ 126      
Derivative notional amounts outstanding 37,000   37,000   34,500  
Cross currency interest rate swaps            
Derivative [Line Items]            
Derivative notional amounts outstanding 5,300   5,300   2,300  
Interest Rate Contract [Member]            
Derivative [Line Items]            
Derivative Liability, Noncurrent 0   0   9  
Derivative notional amounts outstanding 1,100   1,100   1,100  
Equity Securities            
Derivative [Line Items]            
Available-for-sale Securities, Equity Securities $ 697   697   $ 751  
Equity Investments without readily determinable value | Equity Securities            
Derivative [Line Items]            
Equity, Fair Value Adjustment, Impairment Loss     (25)      
Changes in fair value, changes in observable prices     $ 38      
Equity Investments with readily determinable value | Equity Securities            
Derivative [Line Items]            
Unrealized gains on equity investments       $ 354    
Retained Earnings | ASU 2016-01 - Financial Instruments            
Derivative [Line Items]            
Cumulative effect adjustment           $ 232